Product Details



INFLUENZA VACCINES MARKET - GLOBAL FORECAST TO 2023

Influenza Vaccines Market, by Vaccine Type (Trivalent Vaccines and Quadrivalent Vaccines), by Virus Type (Influenza Virus A and Influenza Virus B), by Age Group (Paediatrics and Adults) and by Region - Global Forecast to 2023



The Influenza Vaccines market, in terms of value, is projected to grow at a CAGR of XX% from 2017 to 2023. The market is estimated to be USD XX Million in 2018, and is projected to reach XX Million by 2023. In this study, 2017 has been considered the base year, and 2018 to 2023 the forecast period, for estimating the market size of the global market.

OBJECTIVES OF THE STUDY

  • To define, describe, and forecast the Influenza Vaccines market segmented on the basis of by Vaccine Type (Trivalent Vaccines and Quadrivalent Vaccines), by Virus Type (Influenza Virus A and Influenza Virus B), by Age Group (Pediatrics and Adults) and by Region
  • To forecast the market size in terms of value for various segments with respect to four main regions: North America, Europe, APAC, and RoW
  • To provide detailed information regarding the major factors influencing the growth of the Influenza Vaccines market (drivers, restraints, opportunities, and industry-specific challenges)
  • To provide a detailed overview of the value chain in the Influenza Vaccines market and analyze the market trends with Porter’s five forces analysis
  • To analyze the opportunities in the market for various stakeholders by identifying the high-growth segments of the Influenza Vaccines market
  • To strategically profile the key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for the market leaders
  • To analyze competitive developments such as new product launches and developments; agreements and contracts; mergers and acquisitions; and expansions in the global Influenza Vaccines market

Market Segmentation,

Influenza Vaccines market, By Vaccine Type

Trivalent Vaccines

Quadrivalent Vaccines

Influenza Vaccines market, By Virus Type

Influenza Virus A

Influenza Virus B

Influenza Vaccines market, By Age Group

Pediatrics

Adults

Influenza Vaccines market, By Geography

North America

Europe

Asia Pacific (APAC)

Rest of the World (RoW)

Table of Contents

1 Introduction

2 Research Methodology

3 Executive Summary 

4 Premium Insights
    4.1 Attractive Opportunities in the Influenza Vaccines Market
    4.2 Influenza Vaccines Market, by Vaccine Type
    4.3 Influenza Vaccines Market, by Virus Type
    4.4 Influenza Vaccines Market, by Age Group
    4.5 Influenza Vaccines Market, By Region

5 Market Overview
    5.1 Introduction
    5.2 Value Chain Analysis
    5.3 Market Dynamics
           5.3.1 Drivers
           5.3.2 Restraint
           5.3.3 Opportunities
           5.3.4 Challenges

6 Influenza Vaccines Market, by Vaccine Type
    6.1 Introduction
    6.2 Trivalent Vaccines
    6.2.1 Quadrivalent Vaccines

   7 Influenza Vaccines Market, by Virus Type
    7.1 Introduction
    7.2 Influenza Virus A
    7.3 Influenza Virus B

8 Influenza Vaccines Market, by Age Group
    8.1 Introduction
    8.2 Pediatrics
    8.3 Adults

9 Influenza Vaccines Market, By Geography
    9.1 Introduction
    9.2 North America
    9.3 Europe
    9.4 Asia Pacific
    9.5 Rest of the World (RoW)

10 Competitive Landscapes

11 Company Profiles
    (Business Overview, Financials, Products & Services, Key Developments)*
    11.1 Seqirus Vaccines Limited,
    11.2 GlaxoSmithKline plc,
    11.3 Sanofi Pasteur SA
    11.4 MedImmmune LLC.
    11.5 CSL Limited
    11.6 Merck Sharp & Dohme Corp.
    11.7 Pfizer, Inc.
    11.8 Gamma Vaccines Pty Ltd
    11.9 Sinovac Biotech Ltd
    11.10 OPKO Health, Inc.
    11.11 FluGen,
    11.12 Moderna Therapeutics,
    11.13 Nova ax
    11.14 BioCryst.

                                          *Details Might Not Be Captured in Case of Unlisted Companies.

Single User   1530.00

Multiple User   2200.00
Latest Product